Prostatic Artery Embolization: Indications, Preparation, Techniques, Imaging Evaluation, Reporting, and Complications

Carregando...
Imagem de Miniatura
Citações na Scopus
12
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
RADIOLOGICAL SOC NORTH AMERICA
Citação
RADIOGRAPHICS, v.41, n.5, p.1509-1530, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Benign prostatic hyperplasia (BPH) is a noncancerous growth of the transitional zone of the prostate, which surrounds the prostatic urethra. Consequently, it can cause lower urinary tract symptoms (LUTS) and bladder outlet obstruction symptoms that may substantially reduce a patient's quality of life. Several treatments are available for BPH, including medications such as alpha-blockers and 5 alpha-reductase inhibitors and surgical options including transurethral resection of the prostate and prostatectomy. Recently, prostatic artery embolization (PAE) has emerged as a minimally invasive treatment option for selected men with BPH and moderate to severe LUTS. Adequate pre- and postprocedural evaluations with clinical examinations and questionnaires, laboratory tests, and urodynamic and imaging examinations (particularly US, MRI, and CT) are of key importance to achieve successful treatment. Considering that the use of PAE has been increasing in tertiary hospital facilities, radiologists and interventional radiologists should be aware of the main technical concepts of PAE and the key features to address in imaging reports in pre- and postprocedural settings. An invited commentary by Lopera is available online. Online supplemental material is available for this article. (C) RSNA, 2021
Palavras-chave
Referências
  1. Abdelmoteleb H, 2017, INT BRAZ J UROL, V43, P835, DOI [10.1590/S1677-5538.IBJU.2016.0472, 10.1590/s1677-5538.ibju.2016.0472]
  2. Abt D, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2338
  3. Ahyai SA, 2010, EUR UROL, V58, P384, DOI 10.1016/j.eururo.2010.06.005
  4. Ali R, 2019, ABDOM RADIOL, V44, P713, DOI 10.1007/s00261-018-1757-z
  5. Andrade G, 2019, RADIAT PROT DOSIM, V187, P1, DOI 10.1093/rpd/ncz121
  6. Andrade G, 2017, J VASC INTERV RADIOL, V28, P517, DOI 10.1016/j.jvir.2017.01.005
  7. Angle JF, 2010, J VASC INTERV RADIOL, V21, P1479, DOI 10.1016/j.jvir.2010.06.014
  8. Antunes AA, 2013, CARDIOVASC INTER RAD, V36, P978, DOI 10.1007/s00270-013-0611-5
  9. AUA Practise Guidelines Committee, 2003, J UROLOGY, V170, P530, DOI 10.1097/01.ju.0000078083.38675.79
  10. Auffenberg GB, 2009, UROL CLIN N AM, V36, P443, DOI 10.1016/j.ucl.2009.07.004
  11. Bagla S, 2017, CARDIOVASC INTER RAD, V40, P1694, DOI 10.1007/s00270-017-1700-7
  12. Bagla S, 2013, J VASC INTERV RADIOL, V24, P1603, DOI 10.1016/j.jvir.2013.06.024
  13. Bhatia S, 2018, J VASC INTERV RADIOL, V29, P78, DOI 10.1016/j.jvir.2017.08.022
  14. Bhatia S, 2017, J VASC INTERV RADIOL, V28, P898, DOI 10.1016/j.jvir.2017.02.029
  15. Bilhim T, 2013, J VASC INTERV RADIOL, V24, P1595, DOI 10.1016/j.jvir.2013.06.003
  16. Bosch JLHR, 2008, EUR UROL, V53, P819, DOI 10.1016/j.eururo.2007.08.042
  17. Cardarelli-Leite L, 2019, J VASC INTERV RADIOL, V30, P228, DOI 10.1016/j.jvir.2018.11.027
  18. Carnevale FC, 2020, SOC INTERVENTIONAL R
  19. Carnevale FC, 2016, CARDIOVASC INTER RAD, V39, P44, DOI 10.1007/s00270-015-1202-4
  20. Carnevale FC, 2014, CARDIOVASC INTER RAD, V37, P1602, DOI 10.1007/s00270-014-0908-z
  21. Carnevale FC, 2013, CARDIOVASC INTER RAD, V36, P1452, DOI 10.1007/s00270-013-0680-5
  22. Carnevale FC, 2013, J VASC INTERV RADIOL, V24, P535, DOI 10.1016/j.jvir.2012.12.019
  23. Carnevale FC, 2020, RADIOLOGY, V296, P444, DOI 10.1148/radiol.2020191249
  24. Carnevale FC, 2017, CARDIOVASC INTER RAD, V40, P1321, DOI 10.1007/s00270-017-1687-0
  25. Carnevale FC, 2017, CARDIOVASC INTER RAD, V40, P366, DOI 10.1007/s00270-017-1569-5
  26. Carnevale FC, 2010, CARDIOVASC INTER RAD, V33, P355, DOI 10.1007/s00270-009-9727-z
  27. Chehab MA, 2018, J VASC INTERV RADIOL, V29, P1483, DOI 10.1016/j.jvir.2018.06.007
  28. Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2
  29. Cornelis FH, 2020, CARDIOVASC INTER RAD, V43, P176, DOI 10.1007/s00270-019-02379-3
  30. Cumpanas AA, 2013, UROLOGY, V81, P859, DOI 10.1016/j.urology.2012.12.007
  31. Dahma P, 2017, EUR UROL, V71, P570, DOI 10.1016/j.eururo.2016.09.032
  32. de Assis AM, 2019, CARDIOVASC INTER RAD, V42, P1001, DOI 10.1007/s00270-019-02220-x
  33. de Assis AM, 2019, J VASC INTERV RADIOL, V30, P645, DOI 10.1016/j.jvir.2018.12.734
  34. de Assis AM, 2017, CARDIOVASC INTER RAD, V40, P245, DOI 10.1007/s00270-016-1518-8
  35. de Assis AM, 2015, CARDIOVASC INTER RAD, V38, P855, DOI 10.1007/s00270-015-1114-3
  36. DeMeritt JS, 2000, J VASC INTERV RADIOL, V11, P767, DOI 10.1016/S1051-0443(07)61638-8
  37. Desai H, 2018, J VASC INTERV RADIOL, V29, P229, DOI 10.1016/j.jvir.2017.09.020
  38. Feng KK, 2017, UROL SCI, V28, P166, DOI 10.1016/j.urols.2016.10.004
  39. Foster HE, 2018, J UROLOGY, V200, P612, DOI 10.1016/j.juro.2018.05.048
  40. Frenk NE, 2014, AM J ROENTGENOL, V203, P813, DOI 10.2214/AJR.13.11692
  41. Gao YA, 2014, RADIOLOGY, V270, P920, DOI 10.1148/radiol.13122803
  42. Isaacson AJ, 2019, RADIOGRAPHICS, V39, P1526, DOI 10.1148/rg.2019180195
  43. Isaacson AJ, 2016, AM J ROENTGENOL, V206, P442, DOI 10.2214/AJR.15.15146
  44. Jones P, 2015, UROLOGY, V86, P676, DOI 10.1016/j.urology.2015.05.011
  45. Kim AY, 2018, J VASC INTERV RADIOL, V29, P307, DOI 10.1016/j.jvir.2017.11.001
  46. Kriechenbauer BMT, 2020, CARDIOVASC INTER RAD, V43, P1194, DOI 10.1007/s00270-020-02461-1
  47. Lee JW, 2012, KOREAN J UROL, V53, P478, DOI 10.4111/kju.2012.53.7.478
  48. Lin YT, 2016, CARDIOVASC INTER RAD, V39, P690, DOI 10.1007/s00270-015-1235-8
  49. Maclean D, 2018, CARDIOVASC INTER RAD, V41, P628, DOI 10.1007/s00270-017-1842-7
  50. Maron SZ, 2020, J VASC INTERV RADIOL, V31, P370, DOI 10.1016/j.jvir.2019.11.013
  51. MCNEAL JE, 1981, PROSTATE, V2, P35, DOI 10.1002/pros.2990020105
  52. McVary KT, 2006, AM J MANAG CARE, V12, pS122
  53. McWilliams JP, 2019, J VASC INTERV RADIOL, V30, P627, DOI 10.1016/j.jvir.2019.02.013
  54. Meira M, 2021, J VASC INTERV RADIOL, V32, P106, DOI 10.1016/j.jvir.2020.09.023
  55. Memon A, 2000, Tech Urol, V6, P26
  56. Moreira AM, 2017, CARDIOVASC INTER RAD, V40, P1490, DOI 10.1007/s00270-017-1765-3
  57. Moreira AM, 2013, CARDIOVASC INTER RAD, V36, P1690, DOI 10.1007/s00270-013-0739-3
  58. Lecumberri SN, 2018, RES REP UROL, V10, P17, DOI 10.2147/RRU.S139086
  59. Pisco J, 2013, RADIOLOGY, V266, P668, DOI 10.1148/radiol.12111601
  60. Pisco JM, 2016, J VASC INTERV RADIOL, V27, P1115, DOI 10.1016/j.jvir.2016.04.001
  61. Pisco JM, 2013, EUR RADIOL, V23, P2561, DOI 10.1007/s00330-012-2714-9
  62. Ray AF, 2018, BJU INT, V122, P270, DOI 10.1111/bju.14249
  63. Reich O, 2008, J UROLOGY, V180, P246, DOI 10.1016/j.juro.2008.03.058
  64. Reich O, 2006, EUR UROL, V49, P970, DOI 10.1016/j.eururo.2005.12.072
  65. Ren J, 2015, RADIOL INFECT DIS, V2, P27
  66. Rocha A, 2020, J VASC INTERV RADIOL, V31, pS31
  67. Schott P, 2019, J VASC INTERV RADIOL, V30, P1452, DOI 10.1016/j.jvir.2019.04.040
  68. Seo YM, 2012, INT NEUROUROL J, V16, P187, DOI 10.5213/inj.2012.16.4.187
  69. Sun F, 2016, CARDIOVASC INTER RAD, V39, P161, DOI 10.1007/s00270-015-1238-5
  70. Tapping CR, 2018, CARDIOVASC INTER RAD, V41, P1160, DOI 10.1007/s00270-018-1941-0
  71. Torres D, 2019, J VASC INTERV RADIOL, V30, P638, DOI 10.1016/j.jvir.2019.02.014
  72. Vatakencherry G, 2016, TECH VASC INTERV RAD, V19, P113, DOI 10.1053/j.tvir.2016.04.004
  73. Wang MQ, 2018, J VASC INTERV RADIOL, V29, P1694, DOI 10.1016/j.jvir.2018.06.019
  74. Wang MQ, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0026-5
  75. Zhang HT, 2018, RADIOL MED, V123, P727, DOI 10.1007/s11547-018-0904-5